Spruce Biosciences, Inc. (SPRB)
NASDAQ·Healthcare·Biotechnology
$54.47
-4.75%
Mkt Cap $36.05M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 9, 2026 | $500.00K | — | — | -$12.87 | -$9.58 | +25.56% | — | — |
| Q4 2025 Nov 10, 2025 | — | — | — | -$15.56 | -$14.58 | +6.30% | — | — |
| Q3 2025 Aug 14, 2025 | — | — | — | -$18.05 | -$3.50 | +80.61% | — | — |
| Q2 2025 May 6, 2025 | $250.00K | — | — | -$18.80 | -$24.06 | -27.98% | — | — |
| Q2 2025 Apr 2, 2025 | $885.00K | $697.00K | -21.24% | -$0.24 | -$0.23 | +4.17% | — | — |
| Q4 2024 Nov 11, 2024 | $333.33K | $602.00K | +80.60% | -$20.30 | -$15.79 | +22.22% | — | — |
| Q3 2024 Aug 12, 2024 | $1.49M | $1.61M | +8.05% | -$24.81 | -$16.54 | +33.33% | — | — |
| Q2 2024 May 13, 2024 | $1.16M | $2.00M | +72.59% | -$24.06 | -$21.05 | +12.51% | — | — |
| Q1 2024 Mar 13, 2024 | $1.40M | $2.89M | +106.21% | -$30.83 | -$17.29 | +43.92% | — | — |
| Q4 2023 Nov 13, 2023 | $1.30M | $3.07M | +136.38% | -$25.56 | -$22.56 | +11.74% | — | — |
| Q3 2023 Aug 14, 2023 | $820.00K | $2.17M | +164.02% | -$27.82 | -$24.06 | +13.52% | — | — |
| Q2 2023 May 15, 2023 | $500.00K | $1.96M | +292.80% | -$31.58 | -$30.08 | +4.75% | — | — |
| Q1 2023 Mar 16, 2023 | — | — | — | -$41.35 | -$35.34 | +14.53% | — | — |
| Q4 2022 Nov 10, 2022 | — | — | — | -$40.60 | -$36.09 | +11.11% | — | — |
| Q3 2022 Aug 10, 2022 | — | — | — | -$40.60 | -$38.35 | +5.54% | — | — |
| Q2 2022 May 11, 2022 | — | — | — | -$33.83 | -$37.59 | -11.11% | — | — |
| Q1 2022 Mar 14, 2022 | — | — | — | -$42.86 | -$29.32 | +31.59% | — | — |
| Q4 2021 Nov 15, 2021 | — | — | — | -$42.86 | -$36.84 | +14.05% | — | — |
| Q3 2021 Aug 10, 2021 | — | — | — | -$33.83 | -$37.59 | -11.11% | — | — |
| Q2 2021 May 12, 2021 | — | — | — | -$33.08 | -$31.58 | +4.53% | — | — |